In the latest trading session, 5.46 million Core Scientific Inc (NASDAQ:CORZ) shares changed hands as the company’s beta touched 7.03. With the company’s most recent per share price at $10.03 changed hands at -$0.77 or -7.09% at last look, the market valuation stands at $2.80B. CORZ’s current price is a discount, trading about -85.74% off its 52-week high of $18.63. The share price had its 52-week low at $2.61, which suggests the last value was 73.98% up since then.
Analysts gave the Core Scientific Inc (CORZ) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CORZ as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Core Scientific Inc’s EPS for the current quarter is expected to be 0.03.
Core Scientific Inc (NASDAQ:CORZ) trade information
Instantly CORZ was in red as seen in intraday trades today. With action -19.79%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -28.58%, with the 5-day performance at -19.79% in the red. However, in the 30-day time frame, Core Scientific Inc (NASDAQ:CORZ) is -38.59% down.
The consensus price target for the stock as assigned by Wall Street analysts is 16.5, meaning bulls need an upside of 39.21% from its recent market value. According to analyst projections, CORZ’s forecast low is 14 with 24 as the target high. To hit the forecast high, the stock’s price needs a -139.28% plunge from its current level, while the stock would need to soar -39.58% for it to hit the projected low.
Core Scientific Inc (CORZ) estimates and forecasts
Year-over-year growth is forecast to reach 1.63% up from the last financial year.
Consensus estimates given by 13 financial analysts project the company’s revenue in the current quarter to hit an average of 97.06M. 8 analysts are of the opinion that Core Scientific Inc’s revenue for the current quarter will be 107.16M. The company’s revenue for the corresponding quarters a year ago was 141.93M and 179.29M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -31.62%. The estimates for the next quarter sales put growth at -40.23%. The 2025 estimates are for Core Scientific Inc earnings to decrease by -539.11%.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 6.99 shares estimated at $69.07 million under it, the former controlled 2.50% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 1.79% of the shares, roughly 5.0 shares worth around $49.39 million.
